CW
CC icon

CrossGen Wealth’s Chemours CC Stock Holding History

CrossGen Wealth’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07K Hold
101
– – ﹤0.01% 192
2026
Q1 		$2.23K Hold
101
– – ﹤0.01% 174
2025
Q4 		$1.19K Buy
+101
New +$1.3K ﹤0.01% 180

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

CrossGen Wealth's CC Position: Q2 2026 in Review

CrossGen Wealth held its Chemours (CC) position steady in Q2 2026 at 101 shares worth $2.07K. The position accounts for ﹤0.01% of the portfolio, ranked #192.

CrossGen Wealth first reported a position in CC in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.23K in Q1 2026. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • CrossGen Wealth held 101 shares of Chemours worth $2.07K as of Q2 2026.
  • CrossGen Wealth left its Chemours share count unchanged in Q2 2026.
  • Chemours made up ﹤0.01% of CrossGen Wealth's portfolio in Q2 2026, its #192 holding.
  • CrossGen Wealth first reported a position in Chemours in Q4 2025 and has held it in 3 quarters since.
  • CrossGen Wealth's Chemours position peaked at $2.23K in Q1 2026.
  • 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.